MARKET INTRODUCTION
The insulin delivery systems are used extensively for various purposes. Insulin syringes are categorized by three factors: needle length, needle gauge, and syringe capacity. Manufacturers offer syringes in an eclectic array of styles and sizes. Most syringes available today are disposable and available with micro-fine needles. Insulin pump therapy is being preferred as an alternative delivery method of administrating insulin over insulin pens and needles. Most insulin pens available in the market fall into one of these two categories: reusable insulin pens and disposable insulin pens. Insulin jet injectors are pen-like insulin delivery devices that do not have a needle. These devices deliver small jets of insulin dose with great pressure.
MARKET DYNAMICS
Insulin delivery system Market is driving due to factors such as the upsurge in prevalence of diabetes and improving policies for reimbursement, and availability and affordability of insulin delivery devices. However, factor such as risk and complications associated with the insulin delivery systems and stringent government regulations are expected to hamper the market growth.
MARKET SCOPE
The insulin delivery system Market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of insulin delivery system Market with detailed market segmentation by product type and end user. The insulin delivery system Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in insulin delivery system Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The insulin delivery system Market is segmented on the basis of product type and end user. Based on product type, market is segmented as insulin pens, insulin jet injectors, syringes, insulin pumps. Based on end user, market is segmented as specialty diabetic clinics, hospitals, home care.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the insulin delivery system Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The insulin delivery system Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting insulin delivery system Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the insulin delivery system Market in these regions.
MARKET PLAYERS
The report covers key developments in the insulin delivery system Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Product Type and End user launches, Product Type and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from insulin delivery system Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Zaleplon in the global market. Below mentioned is the list of few companies engaged in the insulin delivery system Market.
The report also includes the profiles of key players in insulin delivery system Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Becton, Dickinson and Company
- Tandem Diabetes Care, Inc.
- Medtronic PLC
- Insulet Corporation
- Novo Nordisk AS
- Eli Lilly and Company,
- Sanofi
- F. Hoffmann-La Roche AG
- West Pharma
- Ypsomed Holding AG
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Insulin Delivery System Market - By Product Type
1.3.2 Insulin Delivery System Market - By End User
1.3.3 Insulin Delivery System Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INSULIN DELIVERY SYSTEM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INSULIN DELIVERY SYSTEM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INSULIN DELIVERY SYSTEM MARKET - GLOBAL MARKET ANALYSIS
6.1. INSULIN DELIVERY SYSTEM - GLOBAL MARKET OVERVIEW
6.2. INSULIN DELIVERY SYSTEM - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INSULIN DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INSULIN PENS
7.3.1. Overview
7.3.2. Insulin Pens Market Forecast and Analysis
7.4. INSULIN JET INJECTORS
7.4.1. Overview
7.4.2. Insulin Jet Injectors Market Forecast and Analysis
7.5. SYRINGES
7.5.1. Overview
7.5.2. Syringes Market Forecast and Analysis
7.6. INSULIN PUMPS
7.6.1. Overview
7.6.2. Insulin Pumps Market Forecast and Analysis
8. INSULIN DELIVERY SYSTEM MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. SPECIALTY DIABETIC CLINICS
8.3.1. Overview
8.3.2. Specialty Diabetic Clinics Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. HOME CARE
8.5.1. Overview
8.5.2. Home care Market Forecast and Analysis
9. INSULIN DELIVERY SYSTEM MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Insulin Delivery System Market Overview
9.1.2 North America Insulin Delivery System Market Forecasts and Analysis
9.1.3 North America Insulin Delivery System Market Forecasts and Analysis - By Product Type
9.1.4 North America Insulin Delivery System Market Forecasts and Analysis - By End User
9.1.5 North America Insulin Delivery System Market Forecasts and Analysis - By Countries
9.1.5.1 United States Insulin Delivery System Market
9.1.5.1.1 United States Insulin Delivery System Market by Product Type
9.1.5.1.2 United States Insulin Delivery System Market by End User
9.1.5.2 Canada Insulin Delivery System Market
9.1.5.2.1 Canada Insulin Delivery System Market by Product Type
9.1.5.2.2 Canada Insulin Delivery System Market by End User
9.1.5.3 Mexico Insulin Delivery System Market
9.1.5.3.1 Mexico Insulin Delivery System Market by Product Type
9.1.5.3.2 Mexico Insulin Delivery System Market by End User
9.2. EUROPE
9.2.1 Europe Insulin Delivery System Market Overview
9.2.2 Europe Insulin Delivery System Market Forecasts and Analysis
9.2.3 Europe Insulin Delivery System Market Forecasts and Analysis - By Product Type
9.2.4 Europe Insulin Delivery System Market Forecasts and Analysis - By End User
9.2.5 Europe Insulin Delivery System Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Insulin Delivery System Market
9.2.5.1.1 Germany Insulin Delivery System Market by Product Type
9.2.5.1.2 Germany Insulin Delivery System Market by End User
9.2.5.2 France Insulin Delivery System Market
9.2.5.2.1 France Insulin Delivery System Market by Product Type
9.2.5.2.2 France Insulin Delivery System Market by End User
9.2.5.3 Italy Insulin Delivery System Market
9.2.5.3.1 Italy Insulin Delivery System Market by Product Type
9.2.5.3.2 Italy Insulin Delivery System Market by End User
9.2.5.4 Spain Insulin Delivery System Market
9.2.5.4.1 Spain Insulin Delivery System Market by Product Type
9.2.5.4.2 Spain Insulin Delivery System Market by End User
9.2.5.5 United Kingdom Insulin Delivery System Market
9.2.5.5.1 United Kingdom Insulin Delivery System Market by Product Type
9.2.5.5.2 United Kingdom Insulin Delivery System Market by End User
9.2.5.6 Rest of Europe Insulin Delivery System Market
9.2.5.6.1 Rest of Europe Insulin Delivery System Market by Product Type
9.2.5.6.2 Rest of Europe Insulin Delivery System Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Insulin Delivery System Market Overview
9.3.2 Asia-Pacific Insulin Delivery System Market Forecasts and Analysis
9.3.3 Asia-Pacific Insulin Delivery System Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Insulin Delivery System Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Insulin Delivery System Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Insulin Delivery System Market
9.3.5.1.1 Australia Insulin Delivery System Market by Product Type
9.3.5.1.2 Australia Insulin Delivery System Market by End User
9.3.5.2 China Insulin Delivery System Market
9.3.5.2.1 China Insulin Delivery System Market by Product Type
9.3.5.2.2 China Insulin Delivery System Market by End User
9.3.5.3 India Insulin Delivery System Market
9.3.5.3.1 India Insulin Delivery System Market by Product Type
9.3.5.3.2 India Insulin Delivery System Market by End User
9.3.5.4 Japan Insulin Delivery System Market
9.3.5.4.1 Japan Insulin Delivery System Market by Product Type
9.3.5.4.2 Japan Insulin Delivery System Market by End User
9.3.5.5 South Korea Insulin Delivery System Market
9.3.5.5.1 South Korea Insulin Delivery System Market by Product Type
9.3.5.5.2 South Korea Insulin Delivery System Market by End User
9.3.5.6 Rest of Asia-Pacific Insulin Delivery System Market
9.3.5.6.1 Rest of Asia-Pacific Insulin Delivery System Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Insulin Delivery System Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Insulin Delivery System Market Overview
9.4.2 Middle East and Africa Insulin Delivery System Market Forecasts and Analysis
9.4.3 Middle East and Africa Insulin Delivery System Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Insulin Delivery System Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Insulin Delivery System Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Insulin Delivery System Market
9.4.5.1.1 South Africa Insulin Delivery System Market by Product Type
9.4.5.1.2 South Africa Insulin Delivery System Market by End User
9.4.5.2 Saudi Arabia Insulin Delivery System Market
9.4.5.2.1 Saudi Arabia Insulin Delivery System Market by Product Type
9.4.5.2.2 Saudi Arabia Insulin Delivery System Market by End User
9.4.5.3 U.A.E Insulin Delivery System Market
9.4.5.3.1 U.A.E Insulin Delivery System Market by Product Type
9.4.5.3.2 U.A.E Insulin Delivery System Market by End User
9.4.5.4 Rest of Middle East and Africa Insulin Delivery System Market
9.4.5.4.1 Rest of Middle East and Africa Insulin Delivery System Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Insulin Delivery System Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Insulin Delivery System Market Overview
9.5.2 South and Central America Insulin Delivery System Market Forecasts and Analysis
9.5.3 South and Central America Insulin Delivery System Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Insulin Delivery System Market Forecasts and Analysis - By End User
9.5.5 South and Central America Insulin Delivery System Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Insulin Delivery System Market
9.5.5.1.1 Brazil Insulin Delivery System Market by Product Type
9.5.5.1.2 Brazil Insulin Delivery System Market by End User
9.5.5.2 Argentina Insulin Delivery System Market
9.5.5.2.1 Argentina Insulin Delivery System Market by Product Type
9.5.5.2.2 Argentina Insulin Delivery System Market by End User
9.5.5.3 Rest of South and Central America Insulin Delivery System Market
9.5.5.3.1 Rest of South and Central America Insulin Delivery System Market by Product Type
9.5.5.3.2 Rest of South and Central America Insulin Delivery System Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INSULIN DELIVERY SYSTEM MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INSULIN DELIVERY SYSTEM MARKET, KEY COMPANY PROFILES
12.1. BECTON, DICKINSON AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TANDEM DIABETES CARE, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MEDTRONIC PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INSULET CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVO NORDISK AS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. F. HOFFMANN-LA ROCHE AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WEST PHARMA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. YPSOMED HOLDING AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Becton, Dickinson and Company
2. Tandem Diabetes Care, Inc.
3. Medtronic PLC
4. Insulet Corporation
5. Novo Nordisk AS
6. Eli Lilly and Company,
7. Sanofi
8. F. Hoffmann-La Roche AG
9. West Pharma
10. Ypsomed Holding AG